Edgar Petru - Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 210 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

285 Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-Cx11/GOG 3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer

Sandro Pignata,Vladyslav Sukhin,Nicoletta Colombo,Jacob Korach, Takashi Matsumoto,Susan Lalondrelle, Julia Vizkeleti,Leslie Randall,Vanessa Samouelian,Pamela Salman,Angelica Nogueira-Rodrigues,Ali Ayhan, Juan F Cueva,Yong Man Kim,Edgar Petru,Karin Yamada,Kan Li,Elizabeth Szamreta,Allison Martin Nguyen,Domenica Lorusso

Oral Sessions (2024)

Cited0Views0Bibtex

Updated Austrian Treatment Algorithm for Metastatic Triple-Negative Breast Cancer

Rupert Bartsch,Gabriel Rinnerthaler,Edgar Petru,Daniel Egle,Michael Gnant,Marija Balic,Thamer Sliwa,Christian Singer

WIENER KLINISCHE WOCHENSCHRIFT（2024）

Cited0Views0WOSBibtex

Abstract PO3-16-10: Real-world Outcomes with First-Line Ribociclib + Endocrine Therapy in Patients with Metastatic HR+, HER2– Breast Cancer: Fourth Interim Analysis of REACH AUT Trial

Christian F. Singer,Daniel Egle,Richard Greil,Edgar Petru,Leopold Oehler,Marija Balic, Laurenz Schöffmann,Georg Pfeiler,Maximilian Marhold,Christine Brunner,Karin Haider,Arik Galid,Ursula Pluschnig,Ferdinand Haslbauer,Michael Hubalek,Andreas Redl, Julia Flatschacher, Shanow Uthman,Bernhard Mraz,Rupert Bartsch

Cancer Researchno. 9_Supplement (2024): PO3-16

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn